Wonik QnC Corporation (KOSDAQ:074600)

Market Cap	476.08B
Revenue (ttm)	906.56B
Net Income (ttm)	50.09B
Shares Out	26.29M
EPS (ttm)	1,905.00
PE Ratio	9.51
Forward PE	11.43
Dividend	100.00 (0.56%)
Ex-Dividend Date	Dec 27, 2024

Volume	434,877
Average Volume	219,696
Open	18,080
Previous Close	18,110
Day's Range	18,080 - 19,200
52-Week Range	15,250 - 30,500
Beta	1.05
RSI	49.79
Earnings Date	Aug 8, 2025

About Revance Therapeutics

Wonik QnC Corporation manufactures and sells quartz and ceramic wares used in the production of semiconductor wafers. The company’s Quartz division provides quartz wares used in the production of semiconductor IC’s, as well as products used in the production of semiconductors, LCDs, LEDs, and solar cells. Its Ceramic division offers ceramics materials, including aluminum nitride, silicon carbide, boron nitride composite, silicon nitride, alumina, zirconia, etc.; parts comprising CVD process AIN nozzles, ALD process SiC susceptors, dry etch proc...

• Industry: Semiconductors
• Sector: Technology
• Founded: 1983
• Employees: 1,170
• Stock Exchange: KOSDAQ
• Ticker Symbol: 074600

Financial Performance

In 2024, Wonik QnC's revenue was 891.54 billion, an increase of 10.62% compared to the previous year's 805.95 billion. Earnings were 50.85 billion, an increase of 33.28%.